C-reactive protein and risk of lung cancer. - Wikidata - awgldk - TriplyDB

C-reactive protein and risk of lung cancer.

C-reactive protein and risk of lung cancer.

http://www.wikidata.org/entity/Q33898168

about

Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort study Heat shock proteins as danger signals for cancer detection Altered methylation in tandem repeat element and elemental component levels in inhalable air particles Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value.Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers Genetic variation across C-reactive protein and risk of prostate cancer.History of periodontal disease diagnosis and lung cancer incidence in the Women's Health Initiative Observational Study.Validation of a blood protein signature for non-small cell lung cancer A review of the application of inflammatory biomarkers in epidemiologic cancer research.Helicobacter pylori seropositivity and risk of lung cancer.C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis.Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.Urinary protein biomarkers in the early detection of lung cancer.Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer Lung cancer chemoprevention with celecoxib in former smokers.Circulating markers of interstitial lung disease and subsequent risk of lung cancer.Factors associated with inflammation markers, a cross-sectional analysis.Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice.Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.Rapid and quantitative detection of C-reactive protein based on quantum dots and immunofiltration assay iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.Genetic polymorphisms in C-reactive protein increase cancer susceptibility Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies.Cancer prevention in HIV-infected populations.Lipopolysaccharide-binding protein is efficient in biodosimetry during radiotherapy of lung cancer

P2860

Q24170267-DE751D66-0806-4F3F-B11B-1E07E9789CF5 Q24273349-669DAA91-EFD0-455C-9433-9A8069583EF6 Q28384728-6B24C828-F255-4440-A43C-FAA2529B9E03 Q28390418-84D2F24B-9E41-401E-843A-BB245A4BD1A2 Q28547421-57ACE1CA-969E-489C-8BCD-53E72F566DC7 Q30664020-E2E66B23-D179-4CAA-940B-E9293DD0E055 Q33713347-234E2FF1-F0DD-4BB5-86B9-2C280D13AA4D Q33777217-6508859C-69B8-435A-BBCA-1219B0EA3CCD Q33981347-F85113EA-EAB9-447D-86A7-C99ED38C2510 Q34008245-BF706846-E611-4EE2-80F1-0BF18D125DB5 Q34135803-048CE83A-396D-4739-81A5-5F71B98EC87F Q34182270-5094E6CE-6585-429C-9B0F-D710DFADA480 Q34389236-2B8751CB-ED25-4D84-AC8C-2A1103EB97DF Q34636595-9EBD03BE-E5DF-4F19-9E30-B9D92468EE11 Q34656726-C3514D9D-661E-4FFF-9882-0D28CE1EC246 Q34747013-8476C8F1-753D-41E8-AA61-1CF3CBA89D61 Q34786853-2ED29D1A-2463-4406-9B75-E85FE415B571 Q34806349-0FBEC4D6-0E81-49EE-A9F7-77A7FB09BB17 Q35007052-FE838F3C-C993-4690-B012-02B6AA897FE6 Q35044516-D26D9418-E949-4550-9C99-3ED27BF84C38 Q35071202-090AD8F2-11E8-4A95-8B32-B818EA7D0269 Q35090585-E096AEAC-00A0-4E2E-BED1-4030390161DC Q35115253-45AFF8B6-F2DF-4B39-B9BF-BE056BDC3E76 Q35156358-1CAF28C6-D830-4124-A1D9-5C78933812E5 Q35291972-60474AF2-F0F3-4B26-952B-9250572A36E4 Q35633792-7080A24D-40D1-4E23-AB1D-258EC90623EB Q35653750-993A08DE-5DDE-4C71-9912-D0B52346830B Q35669716-CC6B7CA2-FD08-49DB-B090-970019606BBE Q35883572-24B99A61-CD3C-4388-95AB-C4B681CBFA03 Q36121363-97AB0825-E320-4121-B351-D1135C5FA4F8 Q36137325-471E6D58-5839-4275-A332-415E1D073113 Q36259789-F9A3152B-25CF-496D-A7E2-9243B5B0C520 Q36367063-39AF3AE4-5ABE-49F7-93A7-84661D1202EB Q36403297-CA73E0BC-70BE-45B1-AEC8-D5314A17C818 Q36486486-5B1B7E72-0B04-47BD-9EFF-1C2A52152095 Q36615808-67B505F9-7CFB-45A4-9210-57EFB25F978D Q36655943-676F5C9C-9147-4D4A-8913-15529E0F6D95 Q36661798-5A7530B3-0B7C-497B-9CDC-E332399586A6 Q36680086-6FB5EBAB-8312-4A5B-9A41-3787C01E990E Q37287997-8A43A0B9-C6A0-4575-9D7C-76FD7F2EA399

P2860

C-reactive protein and risk of lung cancer.

http://www.wikidata.org/entity/Q33898168

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

C-reactive protein and risk of lung cancer.

@ast

C-reactive protein and risk of lung cancer.

@en

type

label

C-reactive protein and risk of lung cancer.

@ast

C-reactive protein and risk of lung cancer.

@en

prefLabel

C-reactive protein and risk of lung cancer.

@ast

C-reactive protein and risk of lung cancer.

@en

P1433

Q33898168-6B8CB80B-F2FE-4FF0-81DA-E2FB83B23F8A

P1476

Q33898168-49D74BE4-5056-4F84-AEDC-7B26D4241919

P2093

Q33898168-12D17CAA-F43B-4FC5-9F98-B70BB2E590B1

Q33898168-3A6EBB8A-3DA8-4DE0-8360-BA74A0A6B3EE

Q33898168-57B4A7EA-58BE-4CC2-B0CC-507CE205E5CE

Q33898168-9EF14415-3A77-4D13-AB9A-C52CC7C38878

Q33898168-A38B8A24-38C2-413F-AA67-2BE59CED303E

Q33898168-E4BC41F4-5570-4E8E-A7FA-6B32A47671E8

Q33898168-FE7E8082-9D79-4CAA-9956-E071AF5EA309

P2860

Q33898168-077EA2BE-A12E-46AC-AF49-159073FC0D9D

Q33898168-0A02D51D-EC66-42F0-AE11-EBC0392FAE29

Q33898168-1D88EE28-42D2-435D-91D2-A75E9947118D

Q33898168-1E908563-42E2-49E1-BE7B-8CE0FB072BE5

Q33898168-26843172-1E20-479A-8F8D-51BE57734564

Q33898168-26ABDDA3-AC6C-49B1-A0C7-1392449E5DBB

Q33898168-2754ABD6-B051-4E97-AE0D-E83B31B07E01

Q33898168-3BCA98F4-09A2-4E61-A124-E75613FA36B0

Q33898168-3BFB5BA9-FD3A-48AC-BF60-40E584E606AA

Q33898168-42FE0707-5539-46C6-9CD2-CAAD120D7C1D

P304

Q33898168-7E28E24F-46EA-4E2D-9494-8456986F3E84

P31

Q33898168-293E1840-D7F2-4C56-BEEC-6E9782A890DC

P356

Q33898168-DB4C5357-710C-42AD-8F6B-EA9010BCA046

P407

Q33898168-9E92A43A-5166-4422-B3CA-62889DD97FB6

P433

Q33898168-9E871709-CA8A-454D-A14B-92586D9D3470

P478

Q33898168-A6F3C2BC-7DE1-484D-8AED-1246174E655C

P50

Q33898168-923ECD03-4571-4FEB-8A0C-DC12902D25A4

Q33898168-C0306E2C-5E9F-40E4-B86A-5FDCC7212E35

P577

Q33898168-D4834F74-FBEB-4DEE-BA2B-09D16AE49579

P698

Q33898168-8F8FBE67-7888-4705-8F6C-5FC56211FD6C

P932

Q33898168-37A1C23D-A982-4CD9-B8DC-2D23D9E256D7

P356

JCO.2009.27.0454

P1433

Journal of Clinical Oncology

P1476

C-reactive protein and risk of lung cancer.

@en

P2093

Anil K Chaturvedi

http://www.w3.org/2001/XMLSchema#string

Eric A Engels

http://www.w3.org/2001/XMLSchema#string

Hormuzd A Katki

http://www.w3.org/2001/XMLSchema#string

Hui-Lee Wong

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

Neil E Caporaso

http://www.w3.org/2001/XMLSchema#string

Sharon R Pine

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

The structure of haplotype blocks in the human genome

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

Epidemiology of lung cancer: looking to the future.

Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

Variations in lung cancer risk among smokers.

Chlamydia pneumoniae and lung cancer: epidemiologic evidence.

Genetic determinants of C-reactive protein.

Genetically elevated C-reactive protein and ischemic vascular disease.

P304

2719-2726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.27.0454

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Nilanjan Chatterjee

Stephen Chanock

P577

2010-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20421535

http://www.w3.org/2001/XMLSchema#string

P932

2881850

http://www.w3.org/2001/XMLSchema#string